This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lin, M.-F. Articles by Garcia-Arenas, R. Search for Related Content PubMed PubMed Citation Articles by Lin, M.-F. Articles by Garcia-Arenas, R.

Expression of Human Prostatic Acid Phosphatase Activity and the Growth of Prostate Carcinoma Cells¹

Department of Urology and Comprehensive Cancer Center, University of Southern California School of Medicine, Los Angeles, California 90033

Human prostatic acid phosphatase (PAcP) is a tissue-specific differentiation antigen and is the major phosphotyrosyl (p-tyr) protein phosphatase in normal differentiated prostate epithelial cells. In prostate carcinomas, cellular PAcP has a low expression. We examined the expression of cellular PAcP activity and its correlation with cell growth that may lead us to understand the role of tyrosine phosphorylation in human prostate cells. LNCaP cells, which expressed the highest cellular PAcP activity, had the slowest growth rate and the lowest p-tyr level among three human prostate carcinoma cell lines: LNCaP, DU145, and PC-3. This inverse correlation was further examined in LNCaP cells, since these cells remain hormone-sensitive. Androgen, a classical stimulator of prostate cells, stimulated the growth of LNCaP cells while cellular PAcP activity decreased and p-tyr levels increased. This phenomenon was also observed when cells were treated with epidermal growth factor and fetal bovine serum. Both epidermal growth factor and fetal bovine serum stimulated the growth of LNCaP cells whereas cellular PAcP activity decreased. Furthermore, when cell growth was arrested at low temperatures (23°C), cellular PAcP activity was elevated. To establish the relationship of cellular PAcP activity with cell growth rate, we transfected a complementary DNA encoding the full length PAcP protein into another human prostate carcinoma line, PC-3, that lacks endogenous PAcP. Two stable transfectants, designated PC-18 and PC-416 cells, were obtained and shown to express PAcP mRNA transcribed from the transfected complementary DNA. The expression of PAcP activity in PC-416 cells, but not PC-18 cells, was associated with a lower p-tyr level and a slower growth rate than control cells transfected with the expression vector alone. In conclusion, in LNCaP cells, the stimulated cell growth is associated with an increased p-tyr level and a decreased cellular PAcP activity. In PAcP complementary DNA-transfected PC-416 cells, the low level of p-tyr corresponds to a slow growth rate.

¹ This work was supported in part by American Cancer Society Grant BC-702, by National Cancer Institute Grant CA 52112, and by NIH BRSG to University of Southern California Medical School.

² To whom requests for reprints should be addressed, at University of Southern California School of Medicine, 2011 Zonal Ave., HMR 901, Los Angeles, CA 90033.

Received 6/20/91. Accepted 6/24/92.

This article has been cited by other articles:

				T.-C. Yuan, S. Veeramani, F.-F. Lin, D. Kondrikou, S. Zelivianski, T. Igawa, D. Karan, S. K. Batra, and M.-F. Lin Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells. Endocr. Relat. Cancer, March 1, 2006; 13(1): 151 - 167. [Abstract] [Full Text] [PDF]

				S. Veeramani, T.-C. Yuan, S.-J. Chen, F.-F. Lin, J. E Petersen, S. Shaheduzzaman, S. Srivastava, R. G MacDonald, and M.-F. Lin Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer Endocr. Relat. Cancer, December 1, 2005; 12(4): 805 - 822. [Abstract] [Full Text] [PDF]

				B. L. Hood, M. M. Darfler, T. G. Guiel, B. Furusato, D. A. Lucas, B. R. Ringeisen, I. A. Sesterhenn, T. P. Conrads, T. D. Veenstra, and D. B. Krizman Proteomic Analysis of Formalin-fixed Prostate Cancer Tissue Mol. Cell. Proteomics, November 1, 2005; 4(11): 1741 - 1753. [Abstract] [Full Text] [PDF]

				S. Zelivianski, R. Glowacki, and M.-F. Lin Transcriptional activation of the human prostatic acid phosphatase gene by NF-{kappa}B via a novel hexanucleotide-binding site Nucleic Acids Res., July 7, 2004; 32(12): 3566 - 3580. [Abstract] [Full Text] [PDF]

				M. Maggiolini, A. Vivacqua, A. Carpino, D. Bonofiglio, G. Fasanella, M. Salerno, D. Picard, and S. Ando The Mutant Androgen Receptor T877A Mediates the Proliferative but Not the Cytotoxic Dose-Dependent Effects of Genistein and Quercetin on Human LNCaP Prostate Cancer Cells Mol. Pharmacol., November 1, 2002; 62(5): 1027 - 1035. [Abstract] [Full Text] [PDF]

				T.-C. Meng and M.-F. Lin Tyrosine Phosphorylation of c-ErbB-2 Is Regulated by the Cellular Form of Prostatic Acid Phosphatase in Human Prostate Cancer Cells J. Biol. Chem., August 21, 1998; 273(34): 22096 - 22104. [Abstract] [Full Text] [PDF]

				M.-F. Lin, T.-C. Meng, P. S. Rao, C. Chang, A. H. Schonthal, and F.-F. Lin Expression of Human Prostatic Acid Phosphatase Correlates with Androgen-stimulated Cell Proliferation in Prostate Cancer Cell Lines J. Biol. Chem., March 6, 1998; 273(10): 5939 - 5947. [Abstract] [Full Text] [PDF]

				G. W. Verhaegh, A. van Bokhoven, F. Smit, J. A. Schalken, and M. J. G. Bussemakers Isolation and Characterization of the Promoter of the Human Prostate Cancer-specific DD3 Gene J. Biol. Chem., November 22, 2000; 275(48): 37496 - 37503. [Abstract] [Full Text] [PDF]

				X.-Q. Zhang, M.-S. Lee, S. Zelivianski, and M.-F. Lin Characterization of a Prostate-specific Tyrosine Phosphatase by Mutagenesis and Expression in Human Prostate Cancer Cells J. Biol. Chem., January 19, 2001; 276(4): 2544 - 2550. [Abstract] [Full Text] [PDF]